Sonnet Biotherapeutics Holdings Inc (SONN) — Capital Reinvestment Ratio

Latest as of September 2018: 1.54x

Sonnet Biotherapeutics Holdings Inc (SONN) has a Capital Reinvestment Ratio of 1.54x as of September 2018, meaning it reinvests 2% of its operating cash flow ($670.16K) in capital expenditures ($1.03 Million). See free cash flow generation of Sonnet Biotherapeutics Holdings Inc to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.54x

Capex / Operating Cash Flow

Operating Cash Flow

$670.16K

USD

Capital Expenditures

$1.03 Million

USD

Data as of

Sep 2018

Most recent filing

Annual Capital Reinvestment Ratio for Sonnet Biotherapeutics Holdings Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Sonnet Biotherapeutics Holdings Inc from None to None. For live market cap and broader valuation context, see SONN market cap overview.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow